Loading…
← CockpitCompetitor Analysis › 300622.SZ Doctorglasses Chain Co. Ltd. Class AOpen in the cockpit ↗

Doctorglasses Chain Co. Ltd. Class A300622.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties
Momentum leader 83
Mkt cap
$710M
US dollars, full cap
Free float
90%
of shares outstanding
$/day
$33.3M
20-day average traded
Fwd P/E
22.8×
forward earnings
ROIC−WACC
+29.0 pp
WACC 5.0%
Hurdle
-19 pp
Req g minus delivered
Next earnings
162 days
29 Apr 2027
Close · CNYCN¥15.28
1D-3.4%
1W-8.9%
1M+4.3%
3M+1.0%
6M-21.8%
YTD-31.1%
1Y-30.6%
ATR %4.7%
52w lowhigh45.0% off high

What Doctorglasses Chain does

Employees: 2,551

Doctorglasses Chain at a glance

Size Doctorglasses Chain (300622.SZ) is a China Health Care company (Medical Specialties) with a market value of $710M, the 2871st largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥15.28 on 18 Nov 2026.

Performance Over six months the shares fell 21.8%, against -15.1% for the median peer and -20.0% for the China market (cap-weighted) — 9th lowest of 21 in its peer set.

Growth Revenue grew 6.0% over the last twelve months (peer median +14.8%); the operating margin is 14.3% (peer median 10.6%).

Valuation It trades at 22.8× forward earnings against a peer median of 26.7× (7th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -19 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 29.0 points above its cost of capital (5.0% WACC).

Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010021 May 202621 Aug 202618 Nov 2026Peer median 86300622.SZ 75
Six months, rebased to 100: Doctorglasses Chain against the median of its 20 peers (local-currency closes).

Doctorglasses Chain financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.45BCN¥1.36BCN¥1.20BCN¥1.17BCN¥960M
Revenue growth—+13%+2%+22%—
Gross profitCN¥990MCN¥786MCN¥703MCN¥700MCN¥555M
EBITDAn/aCN¥328MCN¥295MCN¥327MCN¥261M
Net incomeCN¥192MCN¥149MCN¥104MCN¥128MCN¥75.8M
Free cash flowCN¥287MCN¥291MCN¥255MCN¥264MCN¥180M
Capital expenditureCN¥26.4MCN¥20.7MCN¥26.0MCN¥21.6MCN¥26.3M
Total debtCN¥645MCN¥261MCN¥312MCN¥168MCN¥184M

Quarterly statements and history in the cockpit →

Doctorglasses Chain competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%68841075751501301122301234688085688389491000DCTH688179301367600855002876INMD603108300453002950300622.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Doctorglasses Chain is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%0×200×400×68841075751501301122688085688389DCTH002876INMD603108300463300326300622.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Doctorglasses Chain is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%68841075751501301234688085DCTH688179INMD603108300463300622.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Doctorglasses Chain is the large dot.

Doctorglasses Chain competitors and peer comparison

How Doctorglasses Chain compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Doctorglasses Chain against its 20 peers (data as of 18 Nov 2026)
Measure300622.SZPeer medianRank in peer set
1-month return+4.3%-8.5%5th highest of 21
6-month return-21.8%-15.1%9th lowest of 21
Distance from 52-week high-45.0%-38.2%8th lowest of 21
Revenue growth (TTM)+6.0%+14.8%8th lowest of 21
Operating margin14.3%10.6%10th highest of 21
Forward P/E22.8×26.7×7th cheapest of 17
Growth the price implies (Req g, 7 yrs)-3.4%10.9%3rd least demanding of 17
Growth delivered (Del g)+15.7%+12.1%5th highest of 17
Hurdle (Req g minus delivered)-19.1 pp-5.6 pp4th least demanding of 17
ROIC minus cost of capital+29.0 pp+1.4 pphighest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Doctorglasses Chain 300622.SZChina$710M-22%+6%14%22.8×-3.4%+15.7%
SWS Hemodialysis Care 688410.SSChina$706M-11%+31%19%23.5×16.2%+25.9%
Japan Lifeline 7575.TJapan$703M+34%+6%19%14.5×-9.5%+2.9%
Shanghai INT Medical Instruments 1501.HKHong Kong$700M-25%+35%21%15.9×-3.3%+23.5%
Caina Technology 301122.SZChina$721M+36%+61%0%55.4×n/an/a
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$697M+148%-14%3%n/a31.8%-0.6%
Shanghai Sanyou Medical 688085.SSChina$692M-23%+15%4%50.0×29.0%+6.8%
Shenzhen Lifotronic Technology 688389.SSChina$692M-14%+14%13%29.9×11.6%+13.3%
Livsmed 491000.KSSouth Korea$687M-47%+89%-77%n/an/an/a
Delcath Systems DCTHUnited States$685M+75%+38%5%358.9×33.4%+120.2%
Shanghai Aladdin Biochemical Technology 688179.SSChina$736M-37%+39%24%27.4×17.1%+24.2%
BMC Medical 301367.SZChina$737M-17%+37%17%18.7×-1.5%+15.6%
Beijing Aerospace Changfeng 600855.SSChina$738M-44%-10%-19%n/an/an/a
Shenzhen Sunnypol Optoelectornics 002876.SZChina$680M-9%+29%5%39.0×10.1%+14.2%
InMode INMDUnited States$741M-8%+2%18%9.8×-10.8%+12.4%
Shanghai Runda Medical Technology 603108.SSChina$744M-36%-12%-2%20.5×20.3%-0.2%
Jiang Xi Sanxin Medtec 300453.SZChina$744M-3%+12%18%16.2×-1.9%+11.8%
Allmed Medical Products 002950.SZChina$747M-32%+14%8%n/an/an/a
Sino Medical Sciences Technology 688108.SSChina$753M-41%+22%19%60.0×27.9%+9.9%
Maccura Biotechnology 300463.SZChina$756M-18%-1%-4%421.0×7.9%-10.2%
Shanghai Kinetic Medical 300326.SZChina$662M-10%-28%17%26.0×6.6%-1.9%

Questions

Which companies are Doctorglasses Chain's closest peers?
The cockpit's peer set: SWS Hemodialysis Care (688410.SS), Japan Lifeline (7575.T), Shanghai INT Medical Instruments (1501.HK), Caina Technology (301122.SZ), Anhui Hongyu Wuzhou Medical Manufacturer (301234.SZ), Shanghai Sanyou Medical (688085.SS), Shenzhen Lifotronic Technology (688389.SS), Livsmed (491000.KS).
Is Doctorglasses Chain expensive compared with its peers?
On forward p/e it trades at 22.8× against a peer median of 26.7×, 7th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -19 pp: the price already allows for a slowdown.
How has Doctorglasses Chain stock performed?
Over six months to 18 Nov 2026 the shares returned -21.8% against -15.1% for the median peer; over one year -30.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.